Dr. Eldrin F. Lewis, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 330
Licensed in California since 2020, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
CA license C169157 (first issued 2020; current) -
Cardiovascular Disease Physician
CA license C169157 (first issued 2020; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Stanford Health Care Stanford, CA
- Stanford Health Care Tri-Valley Pleasanton, CA
Medical groups
- Stanford Health Care (3,122 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 330
- Services billed
- 528
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 110 | 94 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 104 | 37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 78 | 33 |
| Established patient office or other outpatient visit, 40-54 minutes | 58 | 50 |
| Established patient office or other outpatient visit, 30-39 minutes | 46 | 34 |
| Established patient office or other outpatient visit, 20-29 minutes | 17 | 15 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 16 |
| Hospital discharge day management, 30 minutes or less | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Jardiance (empagliflozin) Other prescribers in Stanford, CA | 95 |
| Rosuvastatin Calcium Other prescribers in Stanford, CA | 88 |
| Losartan Potassium Other prescribers in Stanford, CA | 76 |
| Spironolactone Other prescribers in Stanford, CA | 61 |
| Entresto (sacubitril/valsartan) Other prescribers in Stanford, CA | 61 |
| Carvedilol Other prescribers in Stanford, CA | 48 |
| Metoprolol Succinate Other prescribers in Stanford, CA | 45 |
| Atorvastatin Calcium Other prescribers in Stanford, CA | 44 |
| Amlodipine Besylate Other prescribers in Stanford, CA | 29 |
| Eliquis (apixaban) Other prescribers in Stanford, CA | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 11 payments worth $30,449 in total to this clinician.
| AstraZeneca UK Limited | $27,184 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $3,222 |
| Cvrx, Inc. | $42.65 |
| Consulting Fee | $30,341 |
|---|---|
| Food and Beverage | $108 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca UK Limited Dec 22, 2025 | Consulting Fee | $19,064 |
| AstraZeneca UK Limited Sep 24, 2025 | Consulting Fee | $6,981 |
| AstraZeneca Pharmaceuticals LP Jul 9, 2025 | Consulting Fee FARXIGA · Cardiovascular and Metabolism Company’s descriptionResearch Related Service | $1,074 |
| AstraZeneca UK Limited Dec 24, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Jul 22, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca UK Limited Dec 8, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Dec 11, 2025 | Consulting Fee FARXIGA · Cardiovascular and Metabolism Company’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Dec 11, 2025 | Consulting Fee FARXIGA · Cardiovascular and Metabolism Company’s descriptionResearch Related Service | $537 |
| AstraZeneca Pharmaceuticals LP Dec 10, 2025 | Consulting Fee FARXIGA · Cardiovascular and Metabolism Company’s descriptionResearch Related Service | $537 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.